KP
Kite Pharma
Venture CapitalModerateKite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
5
Investments
1
Exits
—
AUM
20.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kite Pharma.
Investment Thesis & Strategy
Kite Pharma invests in various stages of biotech and healthcare companies, specifically those developing immune-based therapies for cancer treatment. They seek to develop and design innovative therapies to treat cancer indications.
Investment Activity
Deals per year over the last 1 years
3
2015Portfolio Companies
Selected investments from their portfolio of 5 companies
T
TCR2 Therapeutics
Biotech · Series A, 2015
C
Cell Design Labs
Biotech · Series A, 2015
A
Autolus Therapeutics
Biotech · Series A, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
Kite PharmaAcquisition2017$11.9B
Frequently Asked Questions
Kite Pharma focuses on Series A, Series B, Series C+ stage investments.
Related Investors
MaC Venture Capital
Los Angeles, United States · 126 deals
BAM Ventures
Los Angeles, United States · 119 deals
Strong Ventures
Los Angeles, United States · 101 deals
Sound Ventures
Los Angeles, United States · 97 deals
Manatt Venture Fund
Los Angeles, United States · 67 deals
The Chernin Group
Los Angeles, United States · 67 deals